JANINE ROPER: Open Payments
NPI 1356898159 · GAYLORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 39 payments from 9 companies in 2025. Trend: 2023 $120 · 2024 $265 · 2025 $724
Food & beverage: $724
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $235 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $170 |
| Orexo US, Inc. | 4 | $82 |
| Janssen Pharmaceuticals, Inc | 3 | $68 |
| Indivior Inc. | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Alkermes, Inc. | 1 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Braeburn Inc. | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, Zubsolv, INVEGA SUSTENNA, SUBLOCADE, MAVYRET, Auvelity, VIVITROL.
Industry payments across MI — which companies pay providers there.
